[HTML][HTML] Differentially expressed plasmatic microRNAs in Brazilian patients with Coronavirus disease 2019 (COVID-19): preliminary results

AS Nicoletti, MB Visacri, CRSC da Ronda… - Molecular biology …, 2022 - Springer
Abstract Background Coronavirus disease 2019 (COVID-19) is caused by a novel
coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is known …

Differential microRNA expression in the peripheral blood from human patients with COVID‐19

C Li, X Hu, L Li, J Li - Journal of clinical laboratory analysis, 2020 - Wiley Online Library
Introduction The coronavirus disease (COVID‐19) is caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2), which play important roles in regulating gene …

[HTML][HTML] Circulating microRNA signatures associated with disease severity and outcome in COVID-19 patients

A Giannella, S Riccetti, A Sinigaglia, C Piubelli… - Frontiers in …, 2022 - frontiersin.org
Background SARS-CoV-2 induces a spectrum of clinical conditions ranging from
asymptomatic infection to life threatening severe disease. Host microRNAs have been …

[HTML][HTML] Host miRNAs as biomarkers of SARS-CoV-2 infection: a critical review

K Pollet, N Garnier, S Szunerits, A Madder… - Sensors & …, 2023 - pubs.rsc.org
MicroRNAs (miRNAs), small non-coding RNAs that regulate gene expression, have
received increasing attention as potential biomarkers of different diseases, including viral …

[HTML][HTML] Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection

RJ Farr, CL Rootes, LC Rowntree, THO Nguyen… - PLoS …, 2021 - journals.plos.org
The host response to SARS-CoV-2 infection provide insights into both viral pathogenesis
and patient management. The host-encoded microRNA (miRNA) response to SARS-CoV-2 …

[HTML][HTML] A Comparative Analysis of MicroRNA Expression in Mild, Moderate, and Severe COVID-19: Insights from Urine, Serum, and Nasopharyngeal Samples

R Soltane, N Almulla, A Alasiri, NF Elashmawy… - Biomolecules, 2023 - mdpi.com
COVID-19, caused by the SARS-CoV-2 virus, manifests with a wide range of clinical
symptoms that vary from mild respiratory issues to severe respiratory distress. To effectively …

Altered microRNA expression in severe COVID‐19: Potential prognostic and pathophysiological role

N Garnier, K Pollet, M Fourcot, M Caplan… - Clinical and …, 2022 - Wiley Online Library
Dear Editor, The pathophysiology of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infection is beginning to be elucidated but the role of microRNAs (miRNAs) …

[HTML][HTML] Distinct miRNAs associated with various clinical presentations of SARS-CoV-2 infection

Q Zeng, X Qi, J Ma, F Hu, X Wang, H Qin, M Li… - Iscience, 2022 - cell.com
MicroRNAs (miRNAs) have been shown to play important roles in viral infections, but their
associations with SARS-CoV-2 infection remain poorly understood. Here, we detected 85 …

What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19?

A Guterres, CH de Azeredo Lima, RL Miranda… - Infection, genetics and …, 2020 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of COVID-19,
a pandemic associated with substantial morbidity and mortality. Despite of this, no vaccine …

Plasma miRNA profile at COVID-19 onset predicts severity status and mortality

A Fernández-Pato, A Virseda-Berdices… - Emerging microbes & …, 2022 - Taylor & Francis
Background MicroRNAs (miRNAs) have a crucial role in regulating immune response
against infectious diseases, showing changes early in disease onset and before the …